Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 210727
Company: STEVENS J
Company: STEVENS J
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| DEFERASIROX | DEFERASIROX | 90MG | TABLET;ORAL | Discontinued | None | No | No |
| DEFERASIROX | DEFERASIROX | 360MG | TABLET;ORAL | Discontinued | None | No | No |
| DEFERASIROX | DEFERASIROX | 180MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/15/2020 | ORIG-2 | Approval | STANDARD |
Label is not available on this site. |
|||
| 12/27/2019 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 03/26/2025 | SUPPL-2 | Labeling-Package Insert, Labeling-Medication Guide |
Label is not available on this site. |